Neuralink, Elon Musk's brain implant venture, is on the hunt for its next human trial participant, Musk announced on Friday. The U.S. FDA has also given the green light for Elon Musk's Neuralink to proceed with implanting its brain chip in a second person following a proposal to address issues encountered in its initial patient, as reported by the Wall Street Journal on Monday.
This comes after the company's first trial recipient, Noland Arbaugh, experienced a glitch with his implant just a week ago. The setback arose when tiny wires implanted in the brain of the first patient became displaced, a problem the company was aware of from its animal testing phase, according to Reuters. Neuralink plans to rectify this issue by embedding some of the device's wires deeper into the brain.
Arbaugh, who has been paralyzed since 2016, shared that the implant has significantly improved his life by allowing him to control a computer cursor with his mind. Despite initial success, Arbaugh encountered difficulties when his implant experienced processing speed issues. However, Neuralink sees these challenges as opportunities for improvement, emphasizing the importance of early trials to address such issues before wider deployment.
Neuralink is now looking for more individuals like Arbaugh to test its brain chip technology. Their goal is to connect human brains to computers, potentially aiding paralyzed individuals in controlling devices or assisting blind people in restoring their vision. The company aims to implant its device in the second patient by June, with a total of 10 individuals slated to receive the implant this year. Over 1,000 quadriplegics have reportedly signed up for the company's patient registry. Additionally, Neuralink intends to expand its trials internationally, with plans to submit applications to regulators in Canada and Britain in the coming months.
The current trial, named the PRIME Study, aims to evaluate the safety and functionality of Neuralink's implant and surgical robot. Participants, who suffer from limited hand mobility due to spinal cord injuries or ALS, have chips implanted in the brain region responsible for movement intention. These chips record brain signals, enabling users to control computer cursors or keyboards with their thoughts.
Overall, Neuralink's mission is to revolutionize the way humans interact with technology, offering hope to those with physical disabilities through innovative brain-computer interfaces.
Join us now at FoxAdvert and dive headfirst into an electrifying adventure of marketing mastery! Get ready to discover the hottest industry buzz, unlock game-changing growth tactics, and explore revolutionary measurement solutions at FoxAdvert!
Enhance your digital presence with FoxAdvert, the premier digital marketing agency! Partner with our expert team for targeted advertising strategies, including paid search ads, paid social ads, Apple Search Ads, and ASO services, all designed to deliver exceptional results. Start your journey to success today!
© 2021-2025 FoxAdvert. All Rights Reserved.
